HERCULES, Calif., & VENLO, the Netherlands —  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital […]

DKSH has started a partnership with PacBio, a leading developer of high-quality, highly accurate sequencing solutions to distribute its products in Thailand, Singapore, Vietnam, Indonesia, Philippines, and Malaysia Singapore – DKSH Business Unit Technology has entered a partnership with PacBio, a leading provider of high-quality, highly accurate sequencing solutions for the most complete and accurate […]

The rapid test being developed by Oxford Nanopore, in collaboration with the Quadram Institute Bioscience (QIB), is one of three sequencing-based tests for TB supported by the WHO in a significant step in the global fight against infectious disease.   The World Health Organization (WHO) has announced that a rapid sequencing solution being developed by Oxford […]

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher, 63, was most recently the chief medical officer for Johnson & Johnson (J&J), serving in this capacity from 2012 until her retirement in 2023. As chief medical […]

SomaLogic’s 7,000-plex SomaScan® Platform will be used in proteomics testing at scale in Europe BOULDER, Colo. and L’AQUILA, Italy — SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with Dante Genomics, a global leader in genomics and precision medicine, to offer a comprehensive solution for proteomics testing at […]

SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine™, today announced a strategic partnership to make Pillar’s suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products. The agreement will result in an […]

Comprehensive cloud platform provides industry-leading data quality, security, privacy, and compliance for ongoing service that screens for more than 300 inherited conditions with automated annual re-analysis MOUNTAIN VIEW, Calif., and LA JOLLA, Calif. — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that Fore Genomics, […]

Baylor College of Medicine to utilize spatial genomics tools to continue research into retinal disease  CAMBRIDGE, Mass. — Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced that it has installed its 100th MERSCOPE instrument in the Single Cell Genomics Core at the Baylor College of Medicine Department of […]

ST. LOUIS — Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of Quanta BioDesign, the inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payload delivery design for life science and biopharma applications, by Vector Laboratories, a portfolio company of TSCP and the pioneer […]

PTAB rejects request by Berkeley Lights to reconsider its decision denying Berkeley’s argument that AbCellera’s U.S. patent is invalid VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) announced that the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) has denied a rehearing request in an Inter Partes Review (IPR) filed by Berkeley […]